视网膜大动脉瘤的诊治进展  

Advances in the diagnosis and treatment of retinal artery macroaneurysms

作　　者：陈佳[1] 邹玉凌[2] Jia Chen;Yu-Ling Zou(Department of Ophthalmology,the Second Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China;Department of Fundus Diseases,Affiliated Eye Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China)

机构地区：[1]南昌大学第二附属医院眼科中心,江西省南昌市330006 [2]南昌大学附属眼科医院眼底病科,江西省南昌市330006

出　　处：《国际眼科杂志》2023年第3期395-399,共5页International Eye Science

基　　金：国家自然科学基金项目(No.81860177);江西省自然科学基金面上和杰出青年项目(No.20224BAB206050,2018ACB21041);江西省教育厅科技重点项目(No.GJJ2200125)。

摘　　要：视网膜大动脉瘤(RAM)是一种获得性视网膜血管异常疾病。其发病机制尚未明确,与高血压、动脉硬化、高血脂等全身情况有关。视网膜大动脉瘤由于管壁薄弱高血压情况下易发生渗出或出血引发其他并发症,临床表现复杂多样,不易诊断。瘤体本身有自行退化倾向,病变未累及黄斑区者视力预后良好。但当渗出和/或出血累及黄斑时,严重影响视力,需一些可行性方案治疗。了解视网膜大动脉瘤的典型影像学表现,有助于明确诊断并给予相应的治疗措施。本文主要综述了多种检查方式下视网膜大动脉瘤的表现及不同类型视网膜大动脉瘤对应的多种治疗方案,旨在为未来早期诊断和治疗视网膜大动脉瘤提供参考。·Retinal arterial macroaneurysm(RAM) is a kind of acquired retinal vascular disorder.The pathogenesis of RAM is not yet clear,and it is associated with some systemic conditions,including hypertension,arteriosclerosis and hyperlipidemia.RAM is prone to exudation or bleeding,leading to some other complications in the condition of hypertension due to the weak tube wall,and its clinical manifestations are complex and diverse,which makes it difficult to diagnose.RAM itself has a tendency of self-degeneration,and the prognosis of visual acuity is good if the lesion doesn’t involve the macular area.However,when the macula is affected by exudation and/or bleeding,the vision is severely affected and some feasible treatments are needed.Understanding the typical imaging manifestations of RAM is helpful to make a definite diagnosis and give corresponding treatment measures.In this paper,the manifestations of RAM by various examination methods are reviewed and the corresponding treatments of different types of RAM are summarized,aiming to provide reference for the early diagnosis and treatment of RAM in the future.

关 键 词：视网膜大动脉瘤 荧光素眼底血管造影 光相干断层扫描血管成像 激光治疗 抗血管内皮生长因子治疗 

分 类 号：R774.1[医药卫生—眼科]